Palomino Laboratories (PALX) Annual Balance Sheets

Annual · GAAP · USD millions
Access PALX quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Palomino Laboratories's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2022)
Assets
Cash & cash equivalent8.12
Cash & Short-term Investments8.00
Total loans net0.31
Total Current Assets8.43
Tax Assets, Noncurrent0.73
Total Assets8.43
Liabilities
Accounts Payable0.06
Accrued Liabilities, Current0.37
Short-term Debt0.00
Total Current Liabilities0.34
Long-term debt0.00
Total Long-term Debt0.00
Total Liabilities0.34
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock11.28
Retained Earnings / Accumulated Deficit-3.18
Common Stockholder's Equity8.10
Total Stockholder's Equity8.10
Liabilities & Stockholder's Equity8.43
4 historic quarters locked

Sign in to unlock the full Palomino Laboratories balance sheet history.

About Palomino Laboratories Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-014270

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License